Malaysia’s total industry volume (TIV) could potentially reach up to 800,000 units this year, driven by promotion from both ...

Pharmaceuticals Inc (SCPH) reports a 24% revenue increase and strategic advancements, despite facing significant net losses ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Reimagined recording of the 1988 hit, "It Takes Two." is shining a spotlight on the importance of complete testing and early ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

The following is a summary of “Carotid plaque thickness predicts cardiovascular events and death in patients with chronic ...

Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

Chronic kidney disease (CKD) affects millions worldwide, and as the demand for effective dialysis treatments grows, ...

Mark J. Acierno, DVM, MBA, DACVIM, shares different available options for appetite stimulation and nausea relief in feline ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and EuropeCompleted ZYNQUISTA™ FDA ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.